CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
Lovostatin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00046358
NCT00046358Phase 4Completed
CompareCT.gov

The Effect of Short-Term Statin and NSAID Treatment on CSF Beta-Amyloid

National Institute of Mental Health (NIMH)·interventional·Posted Sep 27, 2002·Updated Mar 4, 2008

In Brief

A Phase 4 clinical trial evaluating Lovostatin and Ibuprofen for Alzheimer Disease. Completed, across 1 site.

Detailed Summary

The purpose of this study is to determine whether short-term use of the drugs ibuprofen and lovastatin affects levels of a protein called beta-amyloid in people who are at risk for developing Alzheimer's Disease (AD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer Disease
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 27, 2002
Enrollment StartSep 1, 2002
Study CompletionAug 1, 2005
TodayJul 2, 2026
Posted 23.8 years ago

Interventions

Lovostatindrug

Ibuprofendrug